BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Trichostatin A
,
rs3825942
,
VEGFA
,
Angiogenesis
,
Leukemia
,
Hippocampus
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carcinoma renal cell
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
OMIM - Cancer
OMIM - Malignant neoplasms
Cancer Gene Census - mutations in cancer genes
The Cancer Genome Atlas (TCGA) mRNA-Seq expression of aggregated samples for several cancers
Explore Curated Studies Results
Literature
Most Relevant Literature
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma.
The role of hyaluronan in renal cell carcinoma.
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic cle…
Normalization methods in mass spectrometry-based analytical proteomics: A case study based on renal …
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepato…
Brivanib Metastatic Renal Cell Carcinoma
Metabolomic Profiling in Renal Cell Carcinoma
Sintilimab in FH-deficient Renal Cell Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ